

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | aminoglycoside antibiotic metabolic process (GO:0030647) | 7.87627513 |
| 2 | somite rostral/caudal axis specification (GO:0032525) | 5.92733631 |
| 3 | maintenance of protein location in nucleus (GO:0051457) | 5.77311295 |
| 4 | neurofilament cytoskeleton organization (GO:0060052) | 5.47270969 |
| 5 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 5.22416569 |
| 6 | proline transport (GO:0015824) | 5.07786553 |
| 7 | regulation of MHC class I biosynthetic process (GO:0045343) | 5.06852276 |
| 8 | regulation of response to osmotic stress (GO:0047484) | 5.03981372 |
| 9 | presynaptic membrane organization (GO:0097090) | 5.03881106 |
| 10 | negative regulation of epidermis development (GO:0045683) | 5.03638599 |
| 11 | presynaptic membrane assembly (GO:0097105) | 5.00817086 |
| 12 | regulation of cilium movement (GO:0003352) | 4.89894667 |
| 13 | phenol-containing compound catabolic process (GO:0019336) | 4.84504403 |
| 14 | glutamate receptor signaling pathway (GO:0007215) | 4.75576752 |
| 15 | serotonin metabolic process (GO:0042428) | 4.64281986 |
| 16 | response to dietary excess (GO:0002021) | 4.60842670 |
| 17 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 4.58047278 |
| 18 | histone H4-K12 acetylation (GO:0043983) | 4.55660337 |
| 19 | locomotory exploration behavior (GO:0035641) | 4.55370818 |
| 20 | negative regulation of telomerase activity (GO:0051974) | 4.54187200 |
| 21 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 4.53544088 |
| 22 | histone H4-K5 acetylation (GO:0043981) | 4.48384017 |
| 23 | histone H4-K8 acetylation (GO:0043982) | 4.48384017 |
| 24 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 4.44299329 |
| 25 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.38681685 |
| 26 | muscle organ morphogenesis (GO:0048644) | 4.33270349 |
| 27 | neuron-neuron synaptic transmission (GO:0007270) | 4.32988825 |
| 28 | regulation of telomere maintenance via telomerase (GO:0032210) | 4.30842482 |
| 29 | positive regulation of amino acid transport (GO:0051957) | 4.25613171 |
| 30 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 4.22747364 |
| 31 | transmission of nerve impulse (GO:0019226) | 4.17705832 |
| 32 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 4.17432862 |
| 33 | negative regulation of cell cycle G2/M phase transition (GO:1902750) | 4.11929849 |
| 34 | synaptic vesicle maturation (GO:0016188) | 4.11297548 |
| 35 | exploration behavior (GO:0035640) | 4.10351991 |
| 36 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 4.09705662 |
| 37 | quinone metabolic process (GO:1901661) | 4.09615007 |
| 38 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 4.08671398 |
| 39 | gamma-aminobutyric acid transport (GO:0015812) | 4.08191002 |
| 40 | primary amino compound metabolic process (GO:1901160) | 4.00588837 |
| 41 | postsynaptic membrane organization (GO:0001941) | 3.98917975 |
| 42 | startle response (GO:0001964) | 3.97416091 |
| 43 | negative regulation of telomere maintenance (GO:0032205) | 3.96841101 |
| 44 | rRNA transcription (GO:0009303) | 3.96383459 |
| 45 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.96032830 |
| 46 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.94424080 |
| 47 | dopamine biosynthetic process (GO:0042416) | 3.94118169 |
| 48 | negative regulation of epidermal cell differentiation (GO:0045605) | 3.92298120 |
| 49 | cytidine deamination (GO:0009972) | 3.90037206 |
| 50 | cytidine metabolic process (GO:0046087) | 3.90037206 |
| 51 | cytidine catabolic process (GO:0006216) | 3.90037206 |
| 52 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.89325521 |
| 53 | mitochondrion distribution (GO:0048311) | 3.88500357 |
| 54 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 3.86420233 |
| 55 | interferon-gamma production (GO:0032609) | 3.86113939 |
| 56 | protein localization to microtubule (GO:0035372) | 3.85702286 |
| 57 | tachykinin receptor signaling pathway (GO:0007217) | 3.85574022 |
| 58 | ventricular system development (GO:0021591) | 3.85496019 |
| 59 | neuron cell-cell adhesion (GO:0007158) | 3.85134086 |
| 60 | cellular potassium ion homeostasis (GO:0030007) | 3.84252199 |
| 61 | coenzyme catabolic process (GO:0009109) | 3.80567097 |
| 62 | negative regulation of microtubule polymerization (GO:0031115) | 3.80315211 |
| 63 | attachment of spindle microtubules to kinetochore (GO:0008608) | 3.77815771 |
| 64 | regulation of postsynaptic membrane potential (GO:0060078) | 3.75678138 |
| 65 | notochord development (GO:0030903) | 3.75147770 |
| 66 | neuron recognition (GO:0008038) | 3.71746576 |
| 67 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.70818675 |
| 68 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.69805559 |
| 69 | regulation of synapse structural plasticity (GO:0051823) | 3.69628115 |
| 70 | cochlea development (GO:0090102) | 3.69311439 |
| 71 | brain morphogenesis (GO:0048854) | 3.66433761 |
| 72 | serotonin receptor signaling pathway (GO:0007210) | 3.63242173 |
| 73 | primitive streak formation (GO:0090009) | 3.63223888 |
| 74 | cell fate commitment involved in formation of primary germ layer (GO:0060795) | 3.61952931 |
| 75 | regulation of synaptic vesicle transport (GO:1902803) | 3.58526577 |
| 76 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 3.58101662 |
| 77 | prepulse inhibition (GO:0060134) | 3.57708842 |
| 78 | axon cargo transport (GO:0008088) | 3.56588738 |
| 79 | protein polyglutamylation (GO:0018095) | 3.55396315 |
| 80 | synaptic vesicle endocytosis (GO:0048488) | 3.53003298 |
| 81 | mitotic sister chromatid segregation (GO:0000070) | 3.50638513 |
| 82 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.49073604 |
| 83 | sodium ion export (GO:0071436) | 3.45777971 |
| 84 | nucleoside transmembrane transport (GO:1901642) | 3.45542750 |
| 85 | protein localization to kinetochore (GO:0034501) | 3.45013328 |
| 86 | positive regulation of synapse assembly (GO:0051965) | 3.44652634 |
| 87 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.44435273 |
| 88 | response to histamine (GO:0034776) | 3.43571292 |
| 89 | regulation of microtubule-based movement (GO:0060632) | 3.42948637 |
| 90 | dendritic spine morphogenesis (GO:0060997) | 3.42702411 |
| 91 | neurotransmitter secretion (GO:0007269) | 3.42507359 |
| 92 | axonal fasciculation (GO:0007413) | 3.41122770 |
| 93 | membrane hyperpolarization (GO:0060081) | 3.40310729 |
| 94 | microtubule severing (GO:0051013) | 3.39425731 |
| 95 | regulation of telomere maintenance (GO:0032204) | 3.39208553 |
| 96 | cullin deneddylation (GO:0010388) | 3.37410007 |
| 97 | layer formation in cerebral cortex (GO:0021819) | 3.36473982 |
| 98 | vocalization behavior (GO:0071625) | 3.35910708 |
| 99 | auditory behavior (GO:0031223) | 3.34004879 |
| 100 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.31307933 |
| 101 | cellular sodium ion homeostasis (GO:0006883) | 3.30868979 |
| 102 | membrane depolarization (GO:0051899) | 3.29152918 |
| 103 | neuronal action potential propagation (GO:0019227) | 3.28770892 |
| 104 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 3.26921189 |
| 105 | response to auditory stimulus (GO:0010996) | 3.25918071 |
| 106 | neurotransmitter transport (GO:0006836) | 3.25847181 |
| 107 | detection of temperature stimulus (GO:0016048) | 3.25085491 |
| 108 | establishment of mitochondrion localization (GO:0051654) | 3.24672744 |
| 109 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.24442824 |
| 110 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.24191412 |
| 111 | regulation of odontogenesis of dentin-containing tooth (GO:0042487) | 3.23939804 |
| 112 | membrane depolarization during action potential (GO:0086010) | 3.23104092 |
| 113 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.22295991 |
| 114 | histone H4-K16 acetylation (GO:0043984) | 3.21988875 |
| 115 | positive regulation of DNA-dependent DNA replication (GO:2000105) | 3.20295356 |
| 116 | regulation of neurotransmitter secretion (GO:0046928) | 3.18951627 |
| 117 | protein localization to microtubule cytoskeleton (GO:0072698) | 3.18785724 |
| 118 | bone trabecula formation (GO:0060346) | 3.17664514 |
| 119 | nucleobase catabolic process (GO:0046113) | 3.17436546 |
| 120 | hormone catabolic process (GO:0042447) | 3.16000867 |
| 121 | short-term memory (GO:0007614) | 3.13788698 |
| 122 | DNA damage response, detection of DNA damage (GO:0042769) | 3.11113013 |
| 123 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.10451832 |
| 124 | rRNA methylation (GO:0031167) | 3.10308028 |
| 125 | cerebellar Purkinje cell layer development (GO:0021680) | 3.09033885 |
| 126 | protein localization to cilium (GO:0061512) | 3.08727701 |
| 127 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.08490294 |
| 128 | cardiovascular system development (GO:0072358) | 3.07629689 |
| 129 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.05244947 |
| 130 | negative regulation of dendrite development (GO:2000171) | 3.03083512 |
| 131 | protein localization to synapse (GO:0035418) | 2.99316099 |
| 132 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.97988835 |
| 133 | regulation of pigment cell differentiation (GO:0050932) | 2.97973489 |
| 134 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.97893890 |
| 135 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.96063355 |
| 136 | righting reflex (GO:0060013) | 2.94634834 |
| 137 | establishment of pigment granule localization (GO:0051905) | 2.92596234 |
| 138 | response to cocaine (GO:0042220) | 2.91671180 |
| 139 | icosanoid secretion (GO:0032309) | 2.91250496 |
| 140 | arachidonic acid secretion (GO:0050482) | 2.91250496 |
| 141 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.91213530 |
| 142 | C4-dicarboxylate transport (GO:0015740) | 2.90929923 |
| 143 | positive regulation of membrane potential (GO:0045838) | 2.90730212 |
| 144 | response to amphetamine (GO:0001975) | 2.90138433 |
| 145 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.90070758 |
| 146 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.89845227 |
| 147 | regulation of neurotransmitter transport (GO:0051588) | 2.89578135 |
| 148 | phosphorelay signal transduction system (GO:0000160) | 2.89474728 |
| 149 | protein localization to cytoskeleton (GO:0044380) | 2.89362887 |
| 150 | microtubule cytoskeleton organization involved in mitosis (GO:1902850) | 2.89166744 |
| 151 | fear response (GO:0042596) | 2.88944656 |
| 152 | regulation of vesicle fusion (GO:0031338) | 2.88870059 |
| 153 | establishment of synaptic vesicle localization (GO:0097480) | 2.88776451 |
| 154 | protein deneddylation (GO:0000338) | 2.84209585 |
| 155 | transepithelial transport (GO:0070633) | 2.83830910 |
| 156 | negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037) | 2.83262256 |
| 157 | pigment granule transport (GO:0051904) | 2.82067613 |
| 158 | nucleoside transport (GO:0015858) | 2.81894531 |
| 159 | positive regulation of digestive system process (GO:0060456) | 2.80862230 |
| 160 | establishment of melanosome localization (GO:0032401) | 2.76188496 |
| 161 | regulation of telomerase activity (GO:0051972) | 2.74982765 |
| 162 | sister chromatid segregation (GO:0000819) | 2.74261752 |
| 163 | phosphatidylinositol 3-kinase signaling (GO:0014065) | 2.71823345 |
| 164 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.71440825 |
| 165 | behavioral defense response (GO:0002209) | 2.71421237 |
| 166 | behavioral fear response (GO:0001662) | 2.71421237 |
| 167 | neurotransmitter uptake (GO:0001504) | 2.69993475 |
| 168 | positive regulation of neurological system process (GO:0031646) | 2.68088394 |
| 169 | head development (GO:0060322) | 2.67105951 |
| 170 | synaptic transmission, glutamatergic (GO:0035249) | 2.66451617 |
| 171 | melanosome transport (GO:0032402) | 2.64313056 |
| 172 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.64274374 |
| 173 | maintenance of protein localization in organelle (GO:0072595) | 2.64023064 |
| 174 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.62687958 |
| 175 | cerebellar granule cell differentiation (GO:0021707) | 2.61436574 |
| 176 | synaptic vesicle exocytosis (GO:0016079) | 2.61057786 |
| 177 | glutamate secretion (GO:0014047) | 2.60523871 |
| 178 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.59388648 |
| 179 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.59047393 |
| 180 | pigment granule localization (GO:0051875) | 2.58776366 |
| 181 | negative regulation of smoothened signaling pathway (GO:0045879) | 2.57678545 |
| 182 | thyroid hormone generation (GO:0006590) | 2.56941295 |
| 183 | rRNA modification (GO:0000154) | 2.56848165 |
| 184 | polyketide metabolic process (GO:0030638) | 12.2798729 |
| 185 | doxorubicin metabolic process (GO:0044598) | 12.2798729 |
| 186 | daunorubicin metabolic process (GO:0044597) | 12.2798729 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.98315123 |
| 2 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 5.52113721 |
| 3 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 5.52113721 |
| 4 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 5.52113721 |
| 5 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.86871915 |
| 6 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.48180478 |
| 7 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 2.94909689 |
| 8 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.91882131 |
| 9 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.83500919 |
| 10 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 2.71696358 |
| 11 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.71496781 |
| 12 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.65281636 |
| 13 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 2.54729098 |
| 14 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 2.29851206 |
| 15 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.26515900 |
| 16 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.22537202 |
| 17 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.20467355 |
| 18 | RNF2_27304074_Chip-Seq_NSC_Mouse | 2.19943891 |
| 19 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.19549626 |
| 20 | IRF1_19129219_ChIP-ChIP_H3396_Human | 2.18657945 |
| 21 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.09910564 |
| 22 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.09772860 |
| 23 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.96284930 |
| 24 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.96213875 |
| 25 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.96213875 |
| 26 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.92360734 |
| 27 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.89530603 |
| 28 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.88650549 |
| 29 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.86908322 |
| 30 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.85344679 |
| 31 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.84733008 |
| 32 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.84361404 |
| 33 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.78318677 |
| 34 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.78231651 |
| 35 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.78065319 |
| 36 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.76303980 |
| 37 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.76255764 |
| 38 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.71845454 |
| 39 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.70467205 |
| 40 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.68341266 |
| 41 | P300_19829295_ChIP-Seq_ESCs_Human | 1.66681413 |
| 42 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.61829296 |
| 43 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.60857026 |
| 44 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.60037495 |
| 45 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.59893462 |
| 46 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.58603359 |
| 47 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.57167261 |
| 48 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.55602728 |
| 49 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.54943520 |
| 50 | * E2F1_17053090_ChIP-ChIP_MCF-7_Human | 1.53817422 |
| 51 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.52035766 |
| 52 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.51196563 |
| 53 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.50832038 |
| 54 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.50281245 |
| 55 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.48192049 |
| 56 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.47337380 |
| 57 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.45600243 |
| 58 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.45455797 |
| 59 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.44963835 |
| 60 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.44950963 |
| 61 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.44672866 |
| 62 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.43045037 |
| 63 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.42587957 |
| 64 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.41925447 |
| 65 | AR_25329375_ChIP-Seq_VCAP_Human | 1.41656578 |
| 66 | TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 1.41281164 |
| 67 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.41115232 |
| 68 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.40085221 |
| 69 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.39434354 |
| 70 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.38476438 |
| 71 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.38210267 |
| 72 | FUS_26573619_Chip-Seq_HEK293_Human | 1.36290900 |
| 73 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.36269464 |
| 74 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.33937320 |
| 75 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.32384833 |
| 76 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.31767220 |
| 77 | STAT3_23295773_ChIP-Seq_U87_Human | 1.29101607 |
| 78 | TCF4_23295773_ChIP-Seq_U87_Human | 1.28513842 |
| 79 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.28487281 |
| 80 | VDR_22108803_ChIP-Seq_LS180_Human | 1.27713322 |
| 81 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.25496380 |
| 82 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.24921023 |
| 83 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.24213812 |
| 84 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.23748707 |
| 85 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.22349449 |
| 86 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.21962265 |
| 87 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.20895749 |
| 88 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.20472390 |
| 89 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 1.20443369 |
| 90 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.20035952 |
| 91 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.19264551 |
| 92 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.17468692 |
| 93 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.16423515 |
| 94 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.16411261 |
| 95 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.15370379 |
| 96 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.13820383 |
| 97 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.13424338 |
| 98 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.13116270 |
| 99 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.12162223 |
| 100 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.11919642 |
| 101 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.11849440 |
| 102 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.11796710 |
| 103 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.11720074 |
| 104 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.11282122 |
| 105 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.10784314 |
| 106 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.10386655 |
| 107 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.10165118 |
| 108 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.10149658 |
| 109 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.09231470 |
| 110 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.08987345 |
| 111 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.08622037 |
| 112 | NANOG_16518401_ChIP-PET_MESCs_Mouse | 1.08170094 |
| 113 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.07554491 |
| 114 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.06946104 |
| 115 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.06674771 |
| 116 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.06423593 |
| 117 | JUN_21703547_ChIP-Seq_K562_Human | 1.05309656 |
| 118 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.04518076 |
| 119 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.04256424 |
| 120 | STAT3_18555785_ChIP-Seq_MESCs_Mouse | 1.03986859 |
| 121 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.03596692 |
| 122 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.02570073 |
| 123 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.02570073 |
| 124 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.02343403 |
| 125 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.01781908 |
| 126 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.01630465 |
| 127 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.01587819 |
| 128 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.00985438 |
| 129 | NANOG_18692474_ChIP-Seq_MESCs_Mouse | 1.00732009 |
| 130 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.00364574 |
| 131 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.99619524 |
| 132 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.99003730 |
| 133 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.98859830 |
| 134 | RXR_22108803_ChIP-Seq_LS180_Human | 0.97001115 |
| 135 | KDM2B_26808549_Chip-Seq_REH_Human | 0.96810696 |
| 136 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.96775712 |
| 137 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.95867210 |
| 138 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.95867210 |
| 139 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.95718277 |
| 140 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.92077147 |
| 141 | POU5F1_18347094_ChIP-ChIP_MESCs_Mouse | 0.91754818 |
| 142 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.89023061 |
| 143 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.88992418 |
| 144 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.87147624 |
| 145 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.87102285 |
| 146 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.85813418 |
| 147 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.85295291 |
| 148 | POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 0.84721563 |
| 149 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.84632887 |
| 150 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.81030334 |
| 151 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.79365730 |
| 152 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.78928505 |
| 153 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.78061363 |
| 154 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.77020708 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003122_maternal_imprinting | 4.84377570 |
| 2 | MP0006292_abnormal_olfactory_placode | 4.42186287 |
| 3 | MP0010386_abnormal_urinary_bladder | 3.47537945 |
| 4 | MP0005394_taste/olfaction_phenotype | 3.34895216 |
| 5 | MP0005499_abnormal_olfactory_system | 3.34895216 |
| 6 | MP0004858_abnormal_nervous_system | 3.24618649 |
| 7 | MP0004264_abnormal_extraembryonic_tissu | 3.08782218 |
| 8 | MP0004742_abnormal_vestibular_system | 2.99597531 |
| 9 | MP0003121_genomic_imprinting | 2.93405828 |
| 10 | MP0003011_delayed_dark_adaptation | 2.91942788 |
| 11 | MP0003890_abnormal_embryonic-extraembry | 2.88386037 |
| 12 | MP0002254_reproductive_system_inflammat | 2.70041332 |
| 13 | MP0003880_abnormal_central_pattern | 2.55054670 |
| 14 | MP0003787_abnormal_imprinting | 2.51564016 |
| 15 | MP0000537_abnormal_urethra_morphology | 2.44386078 |
| 16 | MP0002332_abnormal_exercise_endurance | 2.40173698 |
| 17 | MP0009046_muscle_twitch | 2.27576684 |
| 18 | MP0004859_abnormal_synaptic_plasticity | 2.26243953 |
| 19 | MP0005075_abnormal_melanosome_morpholog | 2.25115568 |
| 20 | MP0003183_abnormal_peptide_metabolism | 2.19083328 |
| 21 | MP0008569_lethality_at_weaning | 2.16782477 |
| 22 | MP0002822_catalepsy | 2.15383380 |
| 23 | MP0002572_abnormal_emotion/affect_behav | 2.12808751 |
| 24 | MP0006276_abnormal_autonomic_nervous | 2.06656645 |
| 25 | MP0003938_abnormal_ear_development | 2.04735090 |
| 26 | MP0003635_abnormal_synaptic_transmissio | 2.03834512 |
| 27 | MP0000678_abnormal_parathyroid_gland | 2.03523011 |
| 28 | MP0006035_abnormal_mitochondrial_morpho | 2.02157584 |
| 29 | MP0001486_abnormal_startle_reflex | 1.99167071 |
| 30 | MP0002277_abnormal_respiratory_mucosa | 1.90017107 |
| 31 | MP0004885_abnormal_endolymph | 1.89620686 |
| 32 | MP0004270_analgesia | 1.88365228 |
| 33 | MP0002063_abnormal_learning/memory/cond | 1.80309263 |
| 34 | MP0002064_seizures | 1.75553967 |
| 35 | MP0005257_abnormal_intraocular_pressure | 1.70588296 |
| 36 | MP0008057_abnormal_DNA_replication | 1.65490590 |
| 37 | MP0009745_abnormal_behavioral_response | 1.60475677 |
| 38 | MP0002734_abnormal_mechanical_nocicepti | 1.58349920 |
| 39 | MP0003123_paternal_imprinting | 1.54925713 |
| 40 | MP0002638_abnormal_pupillary_reflex | 1.52406591 |
| 41 | MP0002733_abnormal_thermal_nociception | 1.52130378 |
| 42 | MP0008789_abnormal_olfactory_epithelium | 1.49175786 |
| 43 | MP0002184_abnormal_innervation | 1.48299292 |
| 44 | MP0004142_abnormal_muscle_tone | 1.47681481 |
| 45 | MP0001905_abnormal_dopamine_level | 1.47433488 |
| 46 | MP0001501_abnormal_sleep_pattern | 1.43177705 |
| 47 | MP0005423_abnormal_somatic_nervous | 1.41618183 |
| 48 | MP0002272_abnormal_nervous_system | 1.41465822 |
| 49 | MP0002653_abnormal_ependyma_morphology | 1.40640424 |
| 50 | MP0000778_abnormal_nervous_system | 1.40075163 |
| 51 | MP0003633_abnormal_nervous_system | 1.35883088 |
| 52 | MP0003329_amyloid_beta_deposits | 1.33582161 |
| 53 | MP0001968_abnormal_touch/_nociception | 1.26447661 |
| 54 | MP0002127_abnormal_cardiovascular_syste | 1.26421891 |
| 55 | MP0000049_abnormal_middle_ear | 1.25296881 |
| 56 | MP0000762_abnormal_tongue_morphology | 1.24720279 |
| 57 | MP0003879_abnormal_hair_cell | 1.23113562 |
| 58 | MP0003631_nervous_system_phenotype | 1.22359561 |
| 59 | MP0001440_abnormal_grooming_behavior | 1.21115217 |
| 60 | MP0002233_abnormal_nose_morphology | 1.20551589 |
| 61 | MP0008775_abnormal_heart_ventricle | 1.20105909 |
| 62 | MP0003137_abnormal_impulse_conducting | 1.20105202 |
| 63 | MP0001970_abnormal_pain_threshold | 1.19563871 |
| 64 | MP0008961_abnormal_basal_metabolism | 1.19247857 |
| 65 | MP0001177_atelectasis | 1.16903951 |
| 66 | MP0004215_abnormal_myocardial_fiber | 1.13706617 |
| 67 | MP0002751_abnormal_autonomic_nervous | 1.13045107 |
| 68 | MP0000631_abnormal_neuroendocrine_gland | 1.12647414 |
| 69 | MP0001502_abnormal_circadian_rhythm | 1.11935068 |
| 70 | MP0000955_abnormal_spinal_cord | 1.11629383 |
| 71 | MP0000920_abnormal_myelination | 1.11547674 |
| 72 | MP0002735_abnormal_chemical_nociception | 1.11280057 |
| 73 | MP0002229_neurodegeneration | 1.11095014 |
| 74 | MP0000538_abnormal_urinary_bladder | 1.09370498 |
| 75 | MP0002932_abnormal_joint_morphology | 1.06431938 |
| 76 | MP0002557_abnormal_social/conspecific_i | 1.06048297 |
| 77 | MP0001529_abnormal_vocalization | 1.05506303 |
| 78 | MP0001188_hyperpigmentation | 1.05351209 |
| 79 | MP0002067_abnormal_sensory_capabilities | 1.04558800 |
| 80 | MP0003632_abnormal_nervous_system | 1.02510288 |
| 81 | MP0001984_abnormal_olfaction | 1.02052721 |
| 82 | MP0002752_abnormal_somatic_nervous | 1.00507529 |
| 83 | MP0009384_cardiac_valve_regurgitation | 0.99195466 |
| 84 | MP0004147_increased_porphyrin_level | 0.98722456 |
| 85 | MP0005645_abnormal_hypothalamus_physiol | 0.98549330 |
| 86 | MP0002114_abnormal_axial_skeleton | 0.95124210 |
| 87 | MP0002882_abnormal_neuron_morphology | 0.92128539 |
| 88 | MP0002909_abnormal_adrenal_gland | 0.91678109 |
| 89 | MP0001293_anophthalmia | 0.90365368 |
| 90 | MP0004043_abnormal_pH_regulation | 0.90246312 |
| 91 | MP0003755_abnormal_palate_morphology | 0.90222254 |
| 92 | MP0006082_CNS_inflammation | 0.89369388 |
| 93 | MP0002163_abnormal_gland_morphology | 0.89212525 |
| 94 | MP0005386_behavior/neurological_phenoty | 0.87702725 |
| 95 | MP0004924_abnormal_behavior | 0.87702725 |
| 96 | MP0008872_abnormal_physiological_respon | 0.83864185 |
| 97 | MP0000569_abnormal_digit_pigmentation | 0.83648245 |
| 98 | MP0001963_abnormal_hearing_physiology | 0.82899493 |
| 99 | MP0005248_abnormal_Harderian_gland | 0.82147846 |
| 100 | MP0003119_abnormal_digestive_system | 0.81754031 |
| 101 | MP0002736_abnormal_nociception_after | 0.81646036 |
| 102 | MP0000566_synostosis | 0.81536329 |
| 103 | MP0005646_abnormal_pituitary_gland | 0.81389240 |
| 104 | MP0004133_heterotaxia | 0.81062635 |
| 105 | MP0001348_abnormal_lacrimal_gland | 0.80779541 |
| 106 | MP0005623_abnormal_meninges_morphology | 0.80728115 |
| 107 | MP0004085_abnormal_heartbeat | 0.80502015 |
| 108 | MP0005253_abnormal_eye_physiology | 0.80248904 |
| 109 | MP0003634_abnormal_glial_cell | 0.78622817 |
| 110 | MP0010030_abnormal_orbit_morphology | 0.78287701 |
| 111 | MP0004811_abnormal_neuron_physiology | 0.77732481 |
| 112 | MP0004957_abnormal_blastocyst_morpholog | 0.77352008 |
| 113 | MP0005535_abnormal_body_temperature | 0.76447923 |
| 114 | MP0008770_decreased_survivor_rate | 0.76023295 |
| 115 | MP0005187_abnormal_penis_morphology | 0.75940424 |
| 116 | MP0002234_abnormal_pharynx_morphology | 0.75827139 |
| 117 | MP0003861_abnormal_nervous_system | 0.75439035 |
| 118 | MP0008874_decreased_physiological_sensi | 0.74907536 |
| 119 | MP0000026_abnormal_inner_ear | 0.74889486 |
| 120 | MP0002066_abnormal_motor_capabilities/c | 0.72680300 |
| 121 | MP0000534_abnormal_ureter_morphology | 0.69725524 |
| 122 | MP0002116_abnormal_craniofacial_bone | 0.69159510 |
| 123 | MP0006072_abnormal_retinal_apoptosis | 0.68595142 |
| 124 | MP0003315_abnormal_perineum_morphology | 0.68471770 |
| 125 | MP0002081_perinatal_lethality | 0.68219374 |
| 126 | MP0005391_vision/eye_phenotype | 0.68029182 |
| 127 | MP0001672_abnormal_embryogenesis/_devel | 0.66742855 |
| 128 | MP0005380_embryogenesis_phenotype | 0.66742855 |
| 129 | MP0000751_myopathy | 0.66247401 |
| 130 | MP0005551_abnormal_eye_electrophysiolog | 0.66166938 |
| 131 | MP0002152_abnormal_brain_morphology | 0.65954930 |
| 132 | MP0001485_abnormal_pinna_reflex | 0.62471171 |
| 133 | MP0000579_abnormal_nail_morphology | 0.60532040 |
| 134 | MP0010770_preweaning_lethality | 0.59046713 |
| 135 | MP0002082_postnatal_lethality | 0.59046713 |
| 136 | MP0003690_abnormal_glial_cell | 0.57808117 |
| 137 | MP0010769_abnormal_survival | 0.57603399 |
| 138 | MP0010768_mortality/aging | 0.56185577 |
| 139 | MP0001943_abnormal_respiration | 0.56096003 |
| 140 | MP0002069_abnormal_eating/drinking_beha | 0.54383702 |
| 141 | MP0003956_abnormal_body_size | 0.50428910 |
| 142 | MP0004084_abnormal_cardiac_muscle | 0.46635270 |
| 143 | MP0005409_darkened_coat_color | 0.45550451 |
| 144 | MP0008877_abnormal_DNA_methylation | 0.44943884 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Bilateral microphthalmos (HP:0007633) | 7.12327278 |
| 2 | Hypochromic microcytic anemia (HP:0004840) | 5.06604528 |
| 3 | Hepatoblastoma (HP:0002884) | 5.05497253 |
| 4 | Action tremor (HP:0002345) | 5.02972453 |
| 5 | Abnormality of the lower motor neuron (HP:0002366) | 4.79490808 |
| 6 | Hyperventilation (HP:0002883) | 4.40647006 |
| 7 | Diplopia (HP:0000651) | 4.24518864 |
| 8 | Abnormality of binocular vision (HP:0011514) | 4.24518864 |
| 9 | Rib fusion (HP:0000902) | 4.01107313 |
| 10 | Bifid tongue (HP:0010297) | 3.67209142 |
| 11 | Neurofibrillary tangles (HP:0002185) | 3.60672574 |
| 12 | Amyotrophic lateral sclerosis (HP:0007354) | 3.57621245 |
| 13 | Febrile seizures (HP:0002373) | 3.57168551 |
| 14 | Nephroblastoma (Wilms tumor) (HP:0002667) | 3.53246585 |
| 15 | Partial duplication of thumb phalanx (HP:0009944) | 3.41963391 |
| 16 | Ulnar claw (HP:0001178) | 3.40509758 |
| 17 | Anomalous pulmonary venous return (HP:0010772) | 3.38406598 |
| 18 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 3.36610585 |
| 19 | Hypoplasia of the fovea (HP:0007750) | 3.36610585 |
| 20 | Horizontal nystagmus (HP:0000666) | 3.32569026 |
| 21 | Sensory axonal neuropathy (HP:0003390) | 3.32329116 |
| 22 | Embryonal renal neoplasm (HP:0011794) | 3.30436866 |
| 23 | Progressive cerebellar ataxia (HP:0002073) | 3.29039511 |
| 24 | Epileptic encephalopathy (HP:0200134) | 3.28177273 |
| 25 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.17806643 |
| 26 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.17806643 |
| 27 | Rectal fistula (HP:0100590) | 3.10736116 |
| 28 | Rectovaginal fistula (HP:0000143) | 3.10736116 |
| 29 | Amblyopia (HP:0000646) | 3.09712233 |
| 30 | Ankle clonus (HP:0011448) | 3.06204822 |
| 31 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.03498561 |
| 32 | Mutism (HP:0002300) | 3.01890885 |
| 33 | Neoplasm of striated muscle (HP:0009728) | 2.98295214 |
| 34 | Multiple enchondromatosis (HP:0005701) | 2.97753154 |
| 35 | Partial duplication of the phalanx of hand (HP:0009999) | 2.96026226 |
| 36 | Supranuclear gaze palsy (HP:0000605) | 2.95191059 |
| 37 | Abnormality of the pulmonary veins (HP:0011718) | 2.93052599 |
| 38 | Spastic tetraparesis (HP:0001285) | 2.89571149 |
| 39 | Ependymoma (HP:0002888) | 2.85570955 |
| 40 | Generalized hypotonia (HP:0001290) | 2.81966302 |
| 41 | Epileptiform EEG discharges (HP:0011182) | 2.81717920 |
| 42 | Progressive inability to walk (HP:0002505) | 2.81190473 |
| 43 | Testicular atrophy (HP:0000029) | 2.79162375 |
| 44 | Esophageal atresia (HP:0002032) | 2.73230602 |
| 45 | Status epilepticus (HP:0002133) | 2.72573872 |
| 46 | Abnormal eating behavior (HP:0100738) | 2.72151378 |
| 47 | Rhabdomyosarcoma (HP:0002859) | 2.66910204 |
| 48 | Intestinal fistula (HP:0100819) | 2.66861601 |
| 49 | Fused cervical vertebrae (HP:0002949) | 2.64025699 |
| 50 | Nasolacrimal duct obstruction (HP:0000579) | 2.63799200 |
| 51 | Broad-based gait (HP:0002136) | 2.59972788 |
| 52 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 2.59854307 |
| 53 | Focal seizures (HP:0007359) | 2.58285107 |
| 54 | Cerebral inclusion bodies (HP:0100314) | 2.55772714 |
| 55 | Dysdiadochokinesis (HP:0002075) | 2.54077132 |
| 56 | Megalencephaly (HP:0001355) | 2.53952405 |
| 57 | Abnormality of the fovea (HP:0000493) | 2.53120751 |
| 58 | Vaginal fistula (HP:0004320) | 2.51935115 |
| 59 | Abnormality of chromosome segregation (HP:0002916) | 2.51108411 |
| 60 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.51108275 |
| 61 | Atonic seizures (HP:0010819) | 2.50894567 |
| 62 | Akinesia (HP:0002304) | 2.50538571 |
| 63 | Abnormality of the phalanges of the hallux (HP:0010057) | 2.49076780 |
| 64 | Torticollis (HP:0000473) | 2.49008390 |
| 65 | Focal motor seizures (HP:0011153) | 2.48994521 |
| 66 | Dialeptic seizures (HP:0011146) | 2.48513712 |
| 67 | Polyphagia (HP:0002591) | 2.46999104 |
| 68 | Abnormal lung lobation (HP:0002101) | 2.46984886 |
| 69 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.45855667 |
| 70 | EEG with generalized epileptiform discharges (HP:0011198) | 2.44745321 |
| 71 | Periauricular skin pits (HP:0100277) | 2.42045870 |
| 72 | Preauricular pit (HP:0004467) | 2.42045870 |
| 73 | Dysmetria (HP:0001310) | 2.41684113 |
| 74 | Chromsome breakage (HP:0040012) | 2.39025862 |
| 75 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.38851172 |
| 76 | Intention tremor (HP:0002080) | 2.37101228 |
| 77 | Supernumerary spleens (HP:0009799) | 2.36947951 |
| 78 | Ragged-red muscle fibers (HP:0003200) | 2.35744195 |
| 79 | Hypsarrhythmia (HP:0002521) | 2.33609073 |
| 80 | Failure to thrive in infancy (HP:0001531) | 2.32155286 |
| 81 | Poor eye contact (HP:0000817) | 2.31946519 |
| 82 | Hemiparesis (HP:0001269) | 2.29644024 |
| 83 | Aplasia/hypoplasia of the humerus (HP:0006507) | 2.26993890 |
| 84 | Impaired smooth pursuit (HP:0007772) | 2.26850829 |
| 85 | Cheilitis (HP:0100825) | 2.25798920 |
| 86 | Abnormality of the corticospinal tract (HP:0002492) | 2.25302100 |
| 87 | Gaze-evoked nystagmus (HP:0000640) | 2.24829398 |
| 88 | Pendular nystagmus (HP:0012043) | 2.20456775 |
| 89 | Neuronal loss in central nervous system (HP:0002529) | 2.20413052 |
| 90 | Urinary urgency (HP:0000012) | 2.20281001 |
| 91 | Molar tooth sign on MRI (HP:0002419) | 2.19562863 |
| 92 | Abnormality of midbrain morphology (HP:0002418) | 2.19562863 |
| 93 | Agnosia (HP:0010524) | 2.18974065 |
| 94 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.18617390 |
| 95 | Abnormality of the astrocytes (HP:0100707) | 2.18603546 |
| 96 | Astrocytoma (HP:0009592) | 2.18603546 |
| 97 | Dyschromatopsia (HP:0007641) | 2.18519736 |
| 98 | Short humerus (HP:0005792) | 2.17690770 |
| 99 | Neoplasm of the heart (HP:0100544) | 2.17540250 |
| 100 | Volvulus (HP:0002580) | 2.17515263 |
| 101 | Upper limb muscle weakness (HP:0003484) | 2.15673985 |
| 102 | Sleep apnea (HP:0010535) | 2.15267296 |
| 103 | Progressive external ophthalmoplegia (HP:0000590) | 2.14419106 |
| 104 | Focal dystonia (HP:0004373) | 2.12533310 |
| 105 | Abnormality of the lacrimal duct (HP:0011481) | 2.11497632 |
| 106 | Abnormality of the labia minora (HP:0012880) | 2.10527440 |
| 107 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.08938224 |
| 108 | 3-Methylglutaconic aciduria (HP:0003535) | 2.06573492 |
| 109 | Abnormality of the salivary glands (HP:0010286) | 2.06452811 |
| 110 | Inability to walk (HP:0002540) | 2.05756589 |
| 111 | Intestinal atresia (HP:0011100) | 2.05615467 |
| 112 | Gastrointestinal atresia (HP:0002589) | 2.03333546 |
| 113 | Increased circulating renin level (HP:0000848) | 2.03269555 |
| 114 | Bradykinesia (HP:0002067) | 2.02962920 |
| 115 | Concave nail (HP:0001598) | 2.02843850 |
| 116 | Postural instability (HP:0002172) | 2.02486490 |
| 117 | Postural tremor (HP:0002174) | 2.02341321 |
| 118 | Generalized tonic-clonic seizures (HP:0002069) | 2.01809706 |
| 119 | Abnormality of the pubic bones (HP:0003172) | 2.01611233 |
| 120 | Hemiplegia (HP:0002301) | 2.01181567 |
| 121 | Exotropia (HP:0000577) | 1.99401736 |
| 122 | Shawl scrotum (HP:0000049) | 1.97087234 |
| 123 | Open mouth (HP:0000194) | 1.96743477 |
| 124 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.96346931 |
| 125 | Tented upper lip vermilion (HP:0010804) | 1.96173348 |
| 126 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.96153253 |
| 127 | Truncal ataxia (HP:0002078) | 1.95041351 |
| 128 | Excessive salivation (HP:0003781) | 1.94383856 |
| 129 | Drooling (HP:0002307) | 1.94383856 |
| 130 | Renal duplication (HP:0000075) | 1.93323932 |
| 131 | Abnormal social behavior (HP:0012433) | 1.92217707 |
| 132 | Impaired social interactions (HP:0000735) | 1.92217707 |
| 133 | Aqueductal stenosis (HP:0002410) | 1.91450998 |
| 134 | Heterotopia (HP:0002282) | 1.90977193 |
| 135 | Esotropia (HP:0000565) | 1.90574479 |
| 136 | Large earlobe (HP:0009748) | 1.89949519 |
| 137 | Cutaneous finger syndactyly (HP:0010554) | 1.89594302 |
| 138 | Duplication of thumb phalanx (HP:0009942) | 1.89069777 |
| 139 | Malignant neoplasm of the central nervous system (HP:0100836) | 1.88862534 |
| 140 | Cerebral hypomyelination (HP:0006808) | 1.87536420 |
| 141 | Abnormality of the nasolacrimal system (HP:0000614) | 1.87500557 |
| 142 | Limb dystonia (HP:0002451) | 1.87323036 |
| 143 | Tetraplegia (HP:0002445) | 1.87026720 |
| 144 | Absence seizures (HP:0002121) | 1.86736197 |
| 145 | Severe visual impairment (HP:0001141) | 1.85710162 |
| 146 | Hypoplasia of the brainstem (HP:0002365) | 1.85181647 |
| 147 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.85181647 |
| 148 | Papilledema (HP:0001085) | 1.84552508 |
| 149 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.84185313 |
| 150 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.83073588 |
| 151 | Spastic tetraplegia (HP:0002510) | 1.83061695 |
| 152 | Broad foot (HP:0001769) | 1.83025931 |
| 153 | Scanning speech (HP:0002168) | 1.80346324 |
| 154 | Depression (HP:0000716) | 1.79237628 |
| 155 | Lissencephaly (HP:0001339) | 1.79118926 |
| 156 | Thickened helices (HP:0000391) | 1.78875558 |
| 157 | Visual hallucinations (HP:0002367) | 1.77952708 |
| 158 | Midline defect of the nose (HP:0004122) | 1.77861746 |
| 159 | Craniofacial dystonia (HP:0012179) | 1.77720620 |
| 160 | Reduced antithrombin III activity (HP:0001976) | 1.77097020 |
| 161 | Abnormal pupillary function (HP:0007686) | 1.76541265 |
| 162 | Preauricular skin tag (HP:0000384) | 1.76248044 |
| 163 | Embryonal neoplasm (HP:0002898) | 1.76129786 |
| 164 | Resting tremor (HP:0002322) | 1.75969340 |
| 165 | Myokymia (HP:0002411) | 1.75657570 |
| 166 | Abnormal biliary tract physiology (HP:0012439) | 1.74807311 |
| 167 | Bile duct proliferation (HP:0001408) | 1.74807311 |
| 168 | Short 5th finger (HP:0009237) | 1.74803372 |
| 169 | Hypothermia (HP:0002045) | 1.71553134 |
| 170 | True hermaphroditism (HP:0010459) | 1.71186049 |
| 171 | Morphological abnormality of the middle ear (HP:0008609) | 1.70856930 |
| 172 | Hypokalemic alkalosis (HP:0001949) | 1.67958348 |
| 173 | Hypoplasia of the corpus callosum (HP:0002079) | 1.67840554 |
| 174 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.67471801 |
| 175 | Oligodactyly (hands) (HP:0001180) | 1.66287553 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GRK5 | 6.05102674 |
| 2 | CDK12 | 6.03716972 |
| 3 | GRK6 | 4.13012820 |
| 4 | ADRBK2 | 3.98676683 |
| 5 | GRK1 | 2.96408283 |
| 6 | GRK7 | 2.76227929 |
| 7 | NTRK3 | 2.49368096 |
| 8 | ERN1 | 2.39953942 |
| 9 | CSF1R | 2.23523350 |
| 10 | MAP2K4 | 2.10100613 |
| 11 | TYRO3 | 2.09616739 |
| 12 | MAPK7 | 2.02000046 |
| 13 | WNK1 | 1.89805869 |
| 14 | MARK1 | 1.83158408 |
| 15 | MOS | 1.81010650 |
| 16 | DAPK2 | 1.77373680 |
| 17 | NTRK1 | 1.74215035 |
| 18 | MAP3K9 | 1.71445111 |
| 19 | FGFR2 | 1.68172793 |
| 20 | MATK | 1.68128907 |
| 21 | CASK | 1.66906485 |
| 22 | TGFBR2 | 1.62880304 |
| 23 | MAP2K7 | 1.56757647 |
| 24 | NTRK2 | 1.53618490 |
| 25 | AKT3 | 1.53587437 |
| 26 | ADRBK1 | 1.49045377 |
| 27 | PINK1 | 1.47566491 |
| 28 | FRK | 1.45572024 |
| 29 | SIK3 | 1.43221412 |
| 30 | MARK2 | 1.42721280 |
| 31 | EPHA4 | 1.40474400 |
| 32 | CAMK4 | 1.40112446 |
| 33 | MAP3K4 | 1.39641814 |
| 34 | TAOK1 | 1.38103036 |
| 35 | SIK2 | 1.35772528 |
| 36 | CAMK2B | 1.23968649 |
| 37 | TTK | 1.21629351 |
| 38 | MAP4K2 | 1.18601010 |
| 39 | SGK494 | 1.17367258 |
| 40 | SGK223 | 1.17367258 |
| 41 | PRPF4B | 1.15148725 |
| 42 | PLK4 | 1.13967622 |
| 43 | PRKG2 | 1.12527485 |
| 44 | CAMKK2 | 1.08658534 |
| 45 | MAPK13 | 1.04420658 |
| 46 | KSR2 | 1.02942557 |
| 47 | LATS2 | 0.98232142 |
| 48 | ARAF | 0.97425710 |
| 49 | MAP3K12 | 0.91996105 |
| 50 | PRKCZ | 0.91123647 |
| 51 | CAMKK1 | 0.90597624 |
| 52 | CDK7 | 0.88113143 |
| 53 | SGK2 | 0.87103595 |
| 54 | MINK1 | 0.86106307 |
| 55 | PKN1 | 0.84741211 |
| 56 | PRKCG | 0.83016628 |
| 57 | ROCK2 | 0.82709780 |
| 58 | MAPK12 | 0.81647641 |
| 59 | SIK1 | 0.79631671 |
| 60 | FES | 0.78149794 |
| 61 | MST4 | 0.77800477 |
| 62 | MAP2K6 | 0.76147471 |
| 63 | PAK6 | 0.75967552 |
| 64 | DYRK1A | 0.75575638 |
| 65 | PLK2 | 0.73515737 |
| 66 | HIPK2 | 0.72024666 |
| 67 | EPHA2 | 0.71699571 |
| 68 | DYRK2 | 0.70840162 |
| 69 | MAP3K11 | 0.69830397 |
| 70 | TSSK6 | 0.68527933 |
| 71 | INSRR | 0.67857609 |
| 72 | ROCK1 | 0.67555067 |
| 73 | CHEK2 | 0.65818240 |
| 74 | TNIK | 0.63746964 |
| 75 | EPHB2 | 0.62959070 |
| 76 | STK10 | 0.61130532 |
| 77 | CDK3 | 0.60284824 |
| 78 | STK11 | 0.59916245 |
| 79 | RIPK4 | 0.59646422 |
| 80 | CDK18 | 0.59643326 |
| 81 | UHMK1 | 0.59369166 |
| 82 | PAK3 | 0.59102011 |
| 83 | PRKG1 | 0.58764002 |
| 84 | PAK4 | 0.58578463 |
| 85 | BRD4 | 0.58574723 |
| 86 | CDK15 | 0.58144798 |
| 87 | EIF2AK2 | 0.56606622 |
| 88 | STK39 | 0.55145186 |
| 89 | FYN | 0.52110732 |
| 90 | CDK5 | 0.51839477 |
| 91 | CDK11A | 0.50650329 |
| 92 | FGFR3 | 0.49832961 |
| 93 | CDK14 | 0.49657465 |
| 94 | MAP3K1 | 0.49241302 |
| 95 | NME1 | 0.49234186 |
| 96 | TNK2 | 0.48395713 |
| 97 | AKT2 | 0.48094209 |
| 98 | MAP2K1 | 0.46784999 |
| 99 | ALK | 0.46238338 |
| 100 | MAPK8 | 0.46033648 |
| 101 | CAMK2G | 0.45932941 |
| 102 | CDK19 | 0.45920943 |
| 103 | CDK8 | 0.45430884 |
| 104 | FGR | 0.43388593 |
| 105 | SGK1 | 0.42527925 |
| 106 | MYLK | 0.42038033 |
| 107 | YES1 | 0.41346134 |
| 108 | CAMK2A | 0.40894167 |
| 109 | PRKCE | 0.39534269 |
| 110 | STK38 | 0.39260051 |
| 111 | CSNK1A1 | 0.38793878 |
| 112 | MAP3K6 | 0.37418502 |
| 113 | SGK3 | 0.37404137 |
| 114 | CLK1 | 0.37113130 |
| 115 | PRKCH | 0.36944052 |
| 116 | PRKCI | 0.36693254 |
| 117 | KSR1 | 0.35986317 |
| 118 | PRKCB | 0.35940008 |
| 119 | PLK1 | 0.35760940 |
| 120 | DAPK1 | 0.34409390 |
| 121 | CHEK1 | 0.34175213 |
| 122 | WEE1 | 0.33525391 |
| 123 | PRKCA | 0.33420273 |
| 124 | MAPK9 | 0.33366467 |
| 125 | PLK3 | 0.33249407 |
| 126 | PRKACA | 0.32289358 |
| 127 | IGF1R | 0.31266318 |
| 128 | CSNK1E | 0.31174297 |
| 129 | MAPK10 | 0.30540318 |
| 130 | OXSR1 | 0.29078879 |
| 131 | CSNK1G2 | 0.27985233 |
| 132 | WNK3 | 0.27957553 |
| 133 | PRKACB | 0.26817694 |
| 134 | PRKCD | 0.26223905 |
| 135 | RPS6KA3 | 0.26221963 |
| 136 | MAPK4 | 0.26213330 |
| 137 | CAMK1 | 0.25326086 |
| 138 | PHKG2 | 0.24303688 |
| 139 | PHKG1 | 0.24303688 |
| 140 | BCR | 0.24011813 |
| 141 | BRAF | 0.23777239 |
| 142 | GSK3B | 0.22250166 |
| 143 | BMPR2 | 0.21891035 |
| 144 | PNCK | 0.20624941 |
| 145 | CSNK1G3 | 0.20452946 |
| 146 | CSK | 0.19804392 |
| 147 | MAP3K7 | 0.19064351 |
| 148 | PRKACG | 0.18608303 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 5.64587041 |
| 2 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 4.22792875 |
| 3 | Nicotine addiction_Homo sapiens_hsa05033 | 3.53469741 |
| 4 | GABAergic synapse_Homo sapiens_hsa04727 | 2.53898342 |
| 5 | Taste transduction_Homo sapiens_hsa04742 | 2.50029735 |
| 6 | Serotonergic synapse_Homo sapiens_hsa04726 | 2.38391109 |
| 7 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.21670138 |
| 8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.21034342 |
| 9 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.07430212 |
| 10 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.00166272 |
| 11 | Long-term potentiation_Homo sapiens_hsa04720 | 1.81814471 |
| 12 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.80622704 |
| 13 | Long-term depression_Homo sapiens_hsa04730 | 1.79510860 |
| 14 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.71565215 |
| 15 | Morphine addiction_Homo sapiens_hsa05032 | 1.68399474 |
| 16 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.64153514 |
| 17 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.60374803 |
| 18 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.58303098 |
| 19 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.57881080 |
| 20 | Circadian entrainment_Homo sapiens_hsa04713 | 1.55520474 |
| 21 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.49037302 |
| 22 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.48469123 |
| 23 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.46479254 |
| 24 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.46435633 |
| 25 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.46405669 |
| 26 | Olfactory transduction_Homo sapiens_hsa04740 | 1.46214733 |
| 27 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.45528781 |
| 28 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.43445400 |
| 29 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.42646233 |
| 30 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.40466294 |
| 31 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.36926410 |
| 32 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.33651664 |
| 33 | Salivary secretion_Homo sapiens_hsa04970 | 1.32519436 |
| 34 | Galactose metabolism_Homo sapiens_hsa00052 | 1.31995620 |
| 35 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.23940534 |
| 36 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.16597596 |
| 37 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.15836895 |
| 38 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.15522853 |
| 39 | Renin secretion_Homo sapiens_hsa04924 | 1.12772067 |
| 40 | Cocaine addiction_Homo sapiens_hsa05030 | 1.11594285 |
| 41 | Axon guidance_Homo sapiens_hsa04360 | 1.10595466 |
| 42 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.09768500 |
| 43 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.08668085 |
| 44 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.08496136 |
| 45 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.06675649 |
| 46 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.06516709 |
| 47 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.04694033 |
| 48 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.03840273 |
| 49 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.99856410 |
| 50 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.98628813 |
| 51 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.92410640 |
| 52 | Alzheimers disease_Homo sapiens_hsa05010 | 0.91650583 |
| 53 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.90909783 |
| 54 | Parkinsons disease_Homo sapiens_hsa05012 | 0.89120591 |
| 55 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.88086743 |
| 56 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.87876418 |
| 57 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.86312697 |
| 58 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.83747405 |
| 59 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.83289220 |
| 60 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.81193126 |
| 61 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.81169191 |
| 62 | Gap junction_Homo sapiens_hsa04540 | 0.81158302 |
| 63 | Insulin secretion_Homo sapiens_hsa04911 | 0.80625924 |
| 64 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.77409289 |
| 65 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.74244649 |
| 66 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.70019432 |
| 67 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.70015394 |
| 68 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.68241687 |
| 69 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.67931004 |
| 70 | Huntingtons disease_Homo sapiens_hsa05016 | 0.67194764 |
| 71 | Prion diseases_Homo sapiens_hsa05020 | 0.66976914 |
| 72 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.66559212 |
| 73 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.65161063 |
| 74 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.64854562 |
| 75 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.64384439 |
| 76 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.62205769 |
| 77 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.62086507 |
| 78 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.61958816 |
| 79 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.61250923 |
| 80 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.61031711 |
| 81 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.60121101 |
| 82 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.59003424 |
| 83 | Phototransduction_Homo sapiens_hsa04744 | 0.57866792 |
| 84 | Bile secretion_Homo sapiens_hsa04976 | 0.56764420 |
| 85 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.56676705 |
| 86 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.55831895 |
| 87 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.54889586 |
| 88 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.54552902 |
| 89 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.54227854 |
| 90 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.53238146 |
| 91 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.53158570 |
| 92 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.52352281 |
| 93 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.51994623 |
| 94 | Thyroid cancer_Homo sapiens_hsa05216 | 0.51315310 |
| 95 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.49323037 |
| 96 | Basal transcription factors_Homo sapiens_hsa03022 | 0.49080579 |
| 97 | Melanogenesis_Homo sapiens_hsa04916 | 0.48146897 |
| 98 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.46865646 |
| 99 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.44402972 |
| 100 | Pathways in cancer_Homo sapiens_hsa05200 | 0.42769115 |
| 101 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.42766036 |
| 102 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.41287761 |
| 103 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.41220138 |
| 104 | Alcoholism_Homo sapiens_hsa05034 | 0.40898265 |
| 105 | Histidine metabolism_Homo sapiens_hsa00340 | 0.40756681 |
| 106 | Protein export_Homo sapiens_hsa03060 | 0.40552910 |
| 107 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.40193778 |
| 108 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.39661760 |
| 109 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.39240201 |
| 110 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.37142824 |
| 111 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.36944353 |
| 112 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.36646344 |
| 113 | Mineral absorption_Homo sapiens_hsa04978 | 0.35084049 |
| 114 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.34117088 |
| 115 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.33628947 |
| 116 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.33112172 |
| 117 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.32658174 |
| 118 | Melanoma_Homo sapiens_hsa05218 | 0.31393890 |
| 119 | Sulfur relay system_Homo sapiens_hsa04122 | 0.31258490 |
| 120 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.30874940 |
| 121 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.30872871 |
| 122 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.30815632 |
| 123 | Glioma_Homo sapiens_hsa05214 | 0.30775763 |
| 124 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.30020634 |
| 125 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.30016168 |
| 126 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.29052138 |
| 127 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.28809649 |
| 128 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.28790520 |
| 129 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.28767613 |
| 130 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.28497867 |
| 131 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.27756536 |
| 132 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.27336218 |
| 133 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.26362854 |
| 134 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.26334838 |
| 135 | Circadian rhythm_Homo sapiens_hsa04710 | 0.23340337 |
| 136 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.22801882 |
| 137 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.22705270 |
| 138 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.15883999 |

